Amniotics announces first patient dosed with PulmoStem™

The clinical study is evaluating the lung-specific stem cell therapy PulmoStem™ in hospitalized patients with severe respiratory infections, including COVID-19, Influenza A, and other causes. Read More

Amniotics stem cell drug PulmoStem™ approved for clinical development

Amniotics AB has received approval by regulatory authorities in UK and Sweden for its first clinical trial with PulmoStem™ .The approval by the Swedish MPA… Read More

Amniotics and Professor Sandra Lindstedt gets SEK 4,8 million from Vinnova

In the research project funded by Vinnova, Amniotics and Professor Sandra Lindstedt at Skåne University Hospital will work together to build a platform to develop… Read More